| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vascular Biology |
From the Vascular Biology Center and Department of Pharmacology (Q.Z., J.E.C., D.J., J.D.C., D.F.), Medical College of Georgia, Augusta; and Department of Pharmacology and Molecular Cardiobiology Division (W.C.S.), Boyer Center for Molecular Medicine, Yale University School of Medicine, New Haven, Conn.
Correspondence to David Fulton, PhD, Vascular Biology Center, Medical College of Georgia, 1459 Laney Walker Blvd, Augusta, GA 30912. E-mail dfulton{at}mcg.edu
Objective We have previously shown in COS-7 cells that targeting of endothelial NO synthase (eNOS) to the Golgi or plasma membrane (PM) regulates the mechanism and degree of eNOS activation. However, little is known about the functional significance of eNOS targeting in endothelial cells (ECs). The goal of the current study was to isolate these 2 pools of enzyme in ECs and determine their functional significance in response to agonist stimulation and manipulation of membrane cholesterol levels.
Methods and Results Using an RNA interference strategy, we generated stable populations of ECs that had >90% inhibition of eNOS expression and lacked the ability to produce NO. Reconstitution of these eNOS "knockdown" ECs with Golgi- and PM-targeted eNOS restored the ability of ECs to produce NO. Calcium-dependent agonists were the more efficient stimulus for the PM-restricted eNOS in ECs. In contrast, Golgi eNOS was less responsive to both calcium- and Akt-dependent agonists. eNOS restricted to the PM was more sensitive to manipulation of membrane cholesterol levels and was significantly attenuated by modified low-density lipoprotein.
Conclusions Within ECs, the PM is the most efficient location to produce NO but is more vulnerable to cholesterol levels and modified low-density lipoprotein.
To determine the functional significance of subcellular targeting in endothelial cells, endogenous eNOS was depleted using virally delivered RNAi and reconstituted with Golgi- and PM-restricted eNOS. We found that the PM is the most efficient location to produce NO but is more vulnerable to cholesterol levels and modified LDL.
Key Words: eNOS cholesterol Golgi plasma membrane RNAi
Related Article:
Arterioscler Thromb Vasc Biol 2006 26: 959-961.
This article has been cited by other articles:
![]() |
H. Wang, A. X. Wang, Z. Liu, W. Chai, and E. J. Barrett The Trafficking/Interaction of eNOS and Caveolin-1 Induced by Insulin Modulates Endothelial Nitric Oxide Production Mol. Endocrinol., October 1, 2009; 23(10): 1613 - 1623. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Peterson, L. V. d'Uscio, S. Cao, X.-L. Wang, and Z. S. Katusic Guanosine Triphosphate Cyclohydrolase I Expression and Enzymatic Activity Are Present in Caveolae of Endothelial Cells Hypertension, February 1, 2009; 53(2): 189 - 195. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. Sanchez, D. D. Kim, R. G. Duran, C. J. Meininger, and W. N. Duran Internalization of eNOS via caveolae regulates PAF-induced inflammatory hyperpermeability to macromolecules Am J Physiol Heart Circ Physiol, October 1, 2008; 295(4): H1642 - H1648. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Zhang, P. Malik, D. Pandey, S. Gupta, D. Jagnandan, E. B. de Chantemele, B. Banfi, M. B. Marrero, R. D. Rudic, D. W. Stepp, et al. Paradoxical Activation of Endothelial Nitric Oxide Synthase by NADPH Oxidase Arterioscler Thromb Vasc Biol, September 1, 2008; 28(9): 1627 - 1633. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-Z. Sheng, F. Arshad, J. E. Braun, and A. P. Braun Estrogen and the Ca2+-mobilizing agonist ATP evoke acute NO synthesis via distinct pathways in an individual human vascular endothelium-derived cell Am J Physiol Cell Physiol, June 1, 2008; 294(6): C1531 - C1541. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hiroi, Z. Guo, Y. Li, A. H. Beggs, and J. K. Liao Dynamic regulation of endothelial NOS mediated by competitive interaction with {alpha}-actinin-4 and calmodulin FASEB J, May 1, 2008; 22(5): 1450 - 1457. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Fulton, L. Ruan, S. G. Sood, C. Li, Q. Zhang, and R. C. Venema Agonist-Stimulated Endothelial Nitric Oxide Synthase Activation and Vascular Relaxation: Role of eNOS Phosphorylation at Tyr83 Circ. Res., February 29, 2008; 102(4): 497 - 504. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Dudzinski and T. Michel Life history of eNOS: Partners and pathways Cardiovasc Res, July 15, 2007; 75(2): 247 - 260. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Jagnandan, J. E. Church, B. Banfi, D. J. Stuehr, M. B. Marrero, and D. J. R. Fulton Novel Mechanism of Activation of NADPH Oxidase 5: CALCIUM SENSITIZATION VIA PHOSPHORYLATION J. Biol. Chem., March 2, 2007; 282(9): 6494 - 6507. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-G. Jin Where is endothelial nitric oxide synthase more critical: plasma membrane or Golgi? Arterioscler Thromb Vasc Biol, May 1, 2006; 26(5): 959 - 961. [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |